Makoto Nogami

Prof. Dr. Makoto Nogami


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2007 in Medical Molecular Morphology
Verified
Journal Article
Closed access
PDF file
MNMakoto Nogami
Makoto Nogami
THTomoaki Hoshi
Tomoaki Hoshi
MKMayumi Kinoshita
Mayumi Kinoshita
TATomomi Arai
Tomomi Arai
MTMichiho Takama
Michiho Takama
ITIchiro Takahashi
Ichiro Takahashi

1 July 2015 in Legal Medicine
Verified
Journal Article
Closed access
HKHiroshi Kameyama
Hiroshi Kameyama
OUOrie Udagawa
Orie Udagawa
THTomoaki Hoshi
Tomoaki Hoshi
YTYoko Toukairin
Yoko Toukairin
TATomomi Arai
Tomomi Arai
MNMakoto Nogami
Makoto Nogami

1 January 2017 in Legal Medicine
Verified
Journal Article
Closed access
YTYoko Toukairin
Yoko Toukairin
TATomomi Arai
Tomomi Arai
THTomoaki Hoshi
Tomoaki Hoshi
JTJuan Alejandro Oliva Trejo
Juan Alejandro Oliva Trejo
MNMakoto Nogami
Makoto Nogami

1 January 2022 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
TNTadashi Nishio
Tadashi Nishio
YTYoko Toukairin
Yoko Toukairin
THTomoaki Hoshi
Tomoaki Hoshi
TATomomi Arai
Tomomi Arai
MNMakoto Nogami
Makoto Nogami

1 September 2009 in Legal Medicine
Verified
Journal Article
Closed access
MNMakoto Nogami
Makoto Nogami
THTomoaki Hoshi
Tomoaki Hoshi
TATomomi Arai
Tomomi Arai
YTYoko Toukairin
Yoko Toukairin
MTMichiho Takama
Michiho Takama
ITIchiro Takahashi
Ichiro Takahashi

12 May 2020 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
MNMakoto Nogami
Makoto Nogami
THTomoaki Hoshi
Tomoaki Hoshi
YTYoko Toukairin
Yoko Toukairin
TATomomi Arai
Tomomi Arai
TNTadashi Nishio
Tadashi Nishio
Objective: Advanced glycation end products (AGEs) are known to play important roles in the development of diabetes mellitus and atherosclerosis. Nε-(carboxymethyl)lysine (CML) is the major AGE, and is found in the arterial walls in the heart. The CML involvement in myocardial ischemia has been reported. We studied the immunohistochemical localization of CML in the hearts from forensic autopsies in relation to the age, serum N-terminal-pro basic natriuretic peptide (NT-proBNP), heart weights, and the degree of peri-myocardial fibrous tissues reflecting coronary microvascular infarction and myocardial remodeling. Results: The CML immunoreactivity in the endothelial cells and intima of arterial walls in the interstitium of ventricular muscles was significantly stronger in the aged group, compatible with the progression of atherosclerosis. The blood level of NT-proBNP, a known useful marker for heart failure, had the positive correlation with the CML immunoreactivity. The degree of fibrosis, heart weights and the histories of hypertension and hyperlipidemia showed positive correlations with the CML immunoreactivity. Our results show the novel positive correlation between the CML immunohistochemistry in the heart vessels and heart conditions, and its future usefulness in the cardiovascular evaluation in histopathology.